S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

3 Underperforming Nasdaq 100 Stocks Worth a Closer Look

Key Points

  • The strategy of rotating to the Nasdaq’s biggest laggards is far from foolproof, but it makes good sense.
  • Despite being down more than 40% year-to-date, analysts still have faith in Enphase Energy.
  • Moderna’s mRNA pipeline includes 45 vaccine and therapeutic candidates.
  • The company also announced a partnership with IBM to explore the use of generative AI and quantum computing in mRNA science.
  • With a consensus price target that implies nearly 80% upside, Zscaler could be one of the Nasdaq-100’s biggest comeback stories of 2023-2024.
  • 5 stocks we like better than Enphase Energy

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

→ Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (From The Oxford Club) (Ad)

Should you invest $1,000 in Enphase Energy right now?

Before you consider Enphase Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enphase Energy wasn't on the list.

While Enphase Energy currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enphase Energy (ENPH)
4.9144 of 5 stars
$118.19-4.3%N/A38.62Moderate Buy$157.66
Moderna (MRNA)
4.5617 of 5 stars
$96.46-3.0%N/A-10.32Hold$124.49
Zscaler (ZS)
3.5265 of 5 stars
$235.23+4.0%N/A-202.78Moderate Buy$216.34
Verizon Communications (VZ)
4.622 of 5 stars
$40.66-0.2%6.54%14.73Moderate Buy$44.00
Intel (INTC)
4.7311 of 5 stars
$42.99+0.0%1.16%110.23Hold$41.48
PDD (PDD)
4.1672 of 5 stars
$127.69-3.0%N/A28.69Buy$128.04
T-Mobile US (TMUS)
4.9279 of 5 stars
$164.34+0.5%1.58%23.71Buy$184.93
Activision Blizzard (ATVI)
0.5636 of 5 stars
$94.42-0.1%1.05%34.59Hold$94.73
Meta Platforms (META)
4.0293 of 5 stars
$484.03-0.4%0.41%32.49Moderate Buy$494.53
Tesla (TSLA)
4.691 of 5 stars
$191.97-2.8%N/A44.54Hold$219.89
Align Technology (ALGN)
4.4917 of 5 stars
$316.88+0.1%N/A54.45Moderate Buy$338.90
Merck & Co., Inc. (MRK)
4.7859 of 5 stars
$129.45+0.1%2.38%924.64Moderate Buy$130.12
International Business Machines (IBM)
4.6589 of 5 stars
$185.72+0.8%3.58%22.84Hold$171.92
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

The Tesla Earnings Story That's NOT Being Told

The Tesla Earnings Story That's NOT Being Told

If the last year of price cuts and sluggish sales weren’t enough to tip off the market to the fact the EV bubble has burst, Tesla’s NASDAQ: TSLA Q4 results and outlook for 2024 should do it.

Search Headlines: